Analysis of Health Sciences Group, Inc. (HESG)
Health Sciences Group, Inc. (HESG) has been showing consistent stability in its stock price over the past few days. The price has been consistently around 0.00001 with no significant fluctuations. Technical indicators such as RSI, MACD, and moving averages (SMA, EMA, WMA) are also indicating stability with values close to zero.
Overall, based on the recent data, Health Sciences Group, Inc. seems to be in a period of consolidation with no clear trend in either direction. Traders and investors may want to wait for a clearer signal or catalyst before making any significant trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Stock statistics reveal details about the company's shares, short interest, and trading volumes. The stock price summary includes metrics like beta, moving averages, and the 52-week high and low prices.
Valuation metrics show the company's price-to-earnings ratios, enterprise value, price-to-book ratio, and market capitalization.
Lastly, dividends and splits information includes details about dividend rates, payout ratios, dividend dates, and historical splits.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe that the company experienced a steady increase in revenue from 2020 to 2022, reaching its peak in 2022. However, there was a slight decrease in revenue in 2023 compared to 2022. This trend indicates a period of growth followed by a slight decline in revenue for the company.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
5. Investing activities include the sale and purchase of investments, capital expenditures, and acquisitions.
6. The end cash position has also been fluctuating, reaching its highest value in 2020.
7. Stock-based compensation is a significant non-cash item in the operating activities section.
8. The company has been managing its cash flow effectively to maintain a healthy financial position.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a range from $1.27 to $1.36. This is higher than the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a range from $1.44 to $1.63. This is slightly higher than the EPS of $1.46 from the same quarter a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.59, with a range from $6.43 to $6.92. This is an increase from the EPS of $6.13 from the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $7.23, with a range from $6.40 to $7.90. This is higher than the EPS of $6.59 from the previous year.
Overall, the analysts are forecasting an increase in earnings per share for both the upcoming quarters and the next two fiscal years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:
- The company is expected to experience a growth rate of 7.5% in the current year.
- The growth rate is projected to increase to 5.6% in the current quarter and further to 4.8% in the next quarter.
- Over the next year, the growth rate is expected to reach 9.7%.
- Looking ahead, the company is forecasted to achieve an annual growth rate of 11% over the next 5 years.
- However, when comparing to the past 5 years, where the company had a growth rate of approximately 20.1% per annum, the future growth rate is expected to be lower.
Overall, the company is expected to maintain a positive growth trajectory, with a slight decrease compared to the growth rate achieved in the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, there is a wide range of estimates, from a low of $164 to a high of $250. The current price of the security is below both the average and median forecast, suggesting that there may be potential for growth according to analysts.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:
1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have also been increasing, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have been increasing steadily, reaching the highest value of $302,083,000,000 in 2022.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current liabilities compared to current liabilities in recent years.
7. The company has been investing more in non-current assets, such as investments and advances, machinery, furniture, and equipment.
8. The company has been maintaining a significant amount of cash and cash equivalents over the years.MACD of HESG